Dr Paul Martin Tesser, MD in Chesterfield, MO - Medicare Ophthalmology

Dr Paul Martin Tesser, MD is a medicare enrolled "Ophthalmology" physician in Chesterfield, Missouri. He went to State University Of New York At Stony Brook, School Of Medicine and graduated in 1991 and has 33 years of diverse experience with area of expertise as Ophthalmology. He is a member of the group practice Glaucoma Consultants Of St Louis Llc and his current practice location is 224 S Woods Mill Rd, Ste. 700s, Chesterfield, Missouri. You can reach out to his office (for appointments etc.) via phone at (314) 469-1122.

Dr Paul Martin Tesser is licensed to practice in Missouri (license number 108445) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1215945720.

Contact Information

	Dr Paul Martin Tesser, MD
	224 S Woods Mill Rd, Ste. 700s, Chesterfield, MO 63017-3451
	(314) 469-1122
	(314) 469-6709

Physician's Profile

Full Name	Dr Paul Martin Tesser
Gender	Male
Speciality	Ophthalmology
Experience	33 Years
Location	224 S Woods Mill Rd, Chesterfield, Missouri
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Paul Martin Tesser attended and graduated from State University Of New York At Stony Brook, School Of Medicine in 1991

NPI Data:

NPI Number: 1215945720
Provider Enumeration Date: 08/03/2006
Last Update Date: 06/27/2008

Medicare PECOS Information:

PECOS PAC ID: 5496656845
Enrollment ID: I20040119000088

Medical Identifiers

Medical identifiers for Dr Paul Martin Tesser such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1215945720	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	108445 (Missouri)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Glaucoma Consultants Of St Louis Llc	0345141792	2

News Archive

Kinaxo partners with Boehringer Ingelheim

Kinaxo Biotechnologies GmbH announced today that it has entered into a two-year collaboration with Boehringer Ingelheim. Under the agreement Kinaxo will apply its new platform technologies to studies on drug mode of action and target identification. Financial details of the agreement were not disclosed.

Tolerx presents otelixizumab preclinical research at 46th EASD

Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the presentation of preclinical research describing the mechanism of action of otelixizumab at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD). In addition, Tolerx also announced that the first European patient was enrolled in DEFEND-2, a confirmatory Phase 3 clinical trial evaluating otelixizumab in autoimmune new-onset type 1 diabetes.

FDA approves manufacture of Amneal Pharmaceuticals' Nizatidine Oral Solution

Amneal Pharmaceuticals is pleased to announce that it has received U.S. FDA approval to manufacture Nizatidine Oral Solution in the 15 mg/mL strength effective November 18, 2009. It is an AA-rated, therapeutically equivalent alternative to Axid® Oral Solution (a licensed trademark of Braintree Labs). Nizatidine Oral Solution is the first available generic in oral solution form and marks Amneal's fourth liquid approval.

Cost of care for benign prostate hyperplasia measured for the first time

UCLA researchers have for the first time described cost across an entire care process for a common condition called benign prostate hyperplasia (BPH) using time-driven activity-based costing. They found a 400 percent discrepancy between the least and most expensive ways to treat the condition.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Paul Martin Tesser allows following entities to bill medicare on his behalf.

Entity Name	Glaucoma Consultants Of St Louis Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1235147661 PECOS PAC ID: 0345141792 Enrollment ID: O20040119000071

News Archive

Kinaxo partners with Boehringer Ingelheim

Tolerx presents otelixizumab preclinical research at 46th EASD

FDA approves manufacture of Amneal Pharmaceuticals' Nizatidine Oral Solution

Cost of care for benign prostate hyperplasia measured for the first time

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Paul Martin Tesser is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Paul Martin Tesser, MD 14319 Wainridge Dr, Chesterfield, MO 63017-2929 Ph: (314) 205-8286	Dr Paul Martin Tesser, MD 224 S Woods Mill Rd, Ste. 700s, Chesterfield, MO 63017-3451 Ph: (314) 469-1122

News Archive

Kinaxo partners with Boehringer Ingelheim

Tolerx presents otelixizumab preclinical research at 46th EASD

FDA approves manufacture of Amneal Pharmaceuticals' Nizatidine Oral Solution

Cost of care for benign prostate hyperplasia measured for the first time

Ophthalmology Doctors in Chesterfield, MO

Mujtaba A Qazi, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1815 Clarkson Rd, Chesterfield, MO 63017 Phone: 636-728-0111 Fax: 636-728-0093
Jonathan Wesley Crews, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1815 Clarkson Rd, Chesterfield, MO 63017 Phone: 636-728-0111 Fax: 636-728-0093
Dr. Steven Miller Shields, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 222 S Woods Mill Rd, Suite 660n, Chesterfield, MO 63017 Phone: 314-878-9902 Fax: 314-878-5112
Dr. Farheen N Kazi Raja, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 222 S Woods Mill Rd Ste 660, Chesterfield, MO 63017 Phone: 314-878-9902 Fax: 314-744-5026
Dr. Dennis Lawrence Ryll, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 390 S Woods Mill Rd, Suite 250, Chesterfield, MO 63017 Phone: 314-503-4196
Dr. Whitney Brothers, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 222 S. Woods Mill Road, Suite 660n, Chesterfield, MO 63017 Phone: 314-878-9902 Fax: 314-878-5112

Dr Paul Martin Tesser, MD - Medicare Ophthalmology in Chesterfield, MO

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Kinaxo partners with Boehringer Ingelheim

Tolerx presents otelixizumab preclinical research at 46th EASD

FDA approves manufacture of Amneal Pharmaceuticals' Nizatidine Oral Solution

Cost of care for benign prostate hyperplasia measured for the first time

Medicare Reassignments

Kinaxo partners with Boehringer Ingelheim

Tolerx presents otelixizumab preclinical research at 46th EASD

FDA approves manufacture of Amneal Pharmaceuticals' Nizatidine Oral Solution

Cost of care for benign prostate hyperplasia measured for the first time

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Kinaxo partners with Boehringer Ingelheim

Tolerx presents otelixizumab preclinical research at 46th EASD

FDA approves manufacture of Amneal Pharmaceuticals' Nizatidine Oral Solution

Cost of care for benign prostate hyperplasia measured for the first time

Ophthalmology Doctors in Chesterfield, MO